Longduoduo Company Limited reported its financial results for the three months ending September 30, 2025, revealing a total revenue of $658,764, a decrease of 14.4% from $769,072 in the same period of the previous year. The company's service revenue fell significantly to $5,606 from $46,595, while commission revenue also declined to $653,158 from $722,477. The gross profit for the quarter was $652,054, down from $736,796 in the prior year, leading to a net loss of $111,182 compared to a loss of $59,504 in the same quarter of 2024.
The company's financial position showed a decline in total assets, which decreased to $1,899,291 from $2,126,496 as of June 30, 2025. Current assets also fell to $1,520,892 from $1,813,587, primarily due to a reduction in cash and cash equivalents, which dropped to $1,247,296 from $1,642,721. On the liabilities side, total liabilities decreased to $700,555 from $830,464, reflecting a reduction in accounts payable and other current liabilities. However, the accumulated deficit increased to $(6,260,151) from $(6,169,197), indicating ongoing challenges in achieving profitability.
Strategically, Longduoduo has been expanding its operations in the preventive healthcare sector, having begun agent sales of healthcare solutions in June 2023. The company has also undergone significant corporate restructuring, consolidating various subsidiaries under its control, which has been reflected in its financial statements. The reverse stock split implemented in September 2023 has been retroactively adjusted in the financials, indicating a focus on optimizing its capital structure.
Operationally, the company reported a decrease in customer engagement metrics, with a notable drop in service revenue impacting overall performance. The total number of shares outstanding remained stable at 30,015,036, and the company continues to maintain a diverse portfolio of subsidiaries focused on healthcare consulting and technology. The employee headcount and specific user statistics were not disclosed in the filing, but the company is actively pursuing growth in its market share within the healthcare sector.
Looking ahead, Longduoduo's management has indicated a commitment to enhancing its service offerings and expanding its market presence. The company aims to leverage its network of third-party healthcare providers to improve revenue streams and operational efficiency. However, the outlook remains cautious due to the recent financial performance and market conditions, with a focus on stabilizing operations and returning to profitability in the upcoming quarters.
About Longduoduo Co Ltd
Longduoduo Company Limited is a Nevada holding company that owns and manages multiple Chinese subsidiaries providing health management and preventive healthcare services. Its core activities include acting as sales agent and distributor for third-party healthcare providers, focusing on cardiovascular and cerebrovascular disease prevention. The company leverages a network of clinics and partnerships in China to deliver high-quality, innovative health solutions to local markets.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.